Phase II trial of INN-108 the treatment of adult orphan ulcerative colitis and mild to moderate ulcerative colitis.

Trial Profile

Phase II trial of INN-108 the treatment of adult orphan ulcerative colitis and mild to moderate ulcerative colitis.

Planning
Phase of Trial: Phase II

Latest Information Update: 06 Jun 2017

At a glance

  • Drugs INN 108 (Primary)
  • Indications Ulcerative colitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Jun 2017 According to an Innovate Biopharmaceuticals media release, the company anticipates to initiate phase II trials of INN-108 in early 2018.
    • 04 Jan 2017 According to an Innovate Biopharmaceuticals media release, the company anticipates to initiate this study in 2017.
    • 05 Dec 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top